Christopher Mutz
Head of Rare Disease
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $471,625 | $3,396,694 |
| 2024 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $447,863 | $2,417,672 |
| 2023 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $424,050 | $1,914,451 |
| 2022 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $408,772 | $1,304,213 |
| 2021 | Ani Pharmaceuticals Inc (ANIP) | Senior Vice President, Head of Rare Disease | $338,462 | $1,605,932 |
Earnings-call appearances
-
Ani Pharmaceuticals Inc Q4 FY2025 Earnings Call2026-01-12
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q3 FY2025 Earnings Call2025-11-07
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q2 FY2025 Earnings Call2025-08-08
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q1 FY2025 Earnings Call2025-05-09
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q4 FY2024 Earnings Call2025-02-28
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q3 FY2024 Earnings Call2024-11-20
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q2 FY2024 Earnings Call2024-08-06
Ani Pharmaceuticals Inc (ANIP)
-
Ani Pharmaceuticals Inc Q3 FY2022 Earnings Call2022-11-09
Ani Pharmaceuticals Inc (ANIP)